Serum neurofilament light-chain (sNfL) levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis (RRMS) patients in the CombiRx trial

被引：0

作者：

Cutter, Gary ^{[1
]}

Rudick, Richard A. ^{[2
]}

De Moor, Carl ^{[2
]}

Singh, Carol M. ^{[2
]}

Fisher, Elizabeth ^{[2
]}

Lublin, Fred D. ^{[3
,4
]}

Wolinsky, Jerry S. ^{[5
]}

McFarland, Henry ^{[6
]}

Jacobson, Steven ^{[7
]}

Naylor, Maria L. ^{[2
]}

机构：

[1] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA

[2] Biogen, Cambridge, MA USA

[3] Icahn Sch Med Mt Sinai, Dept Neurol, Corinne Goldsmith Dickinson Ctr Multiple Scleros, New York, NY 10029 USA

[4] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA

[5] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA

[6] Natl Inst Neurol Disorders & Stroke, NIH, Bethesda, MD USA

[7] Natl Inst Neurol Disorders & Stroke, Viral Immunol Sect, NIH, Bethesda, MD USA

来源：

NEUROLOGY | 2021年 / 96卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

2410

引用

页数：4

共 50 条

[21] Long-term outcome of minocycline in relapsing-remitting multiple sclerosis
Zhang, Y.
Metz, L. M.
Yong, V. W.
Bell, R. B.
Yeung, M.
Patry, D.
Mitchel, J. R.
MULTIPLE SCLEROSIS, 2007, 13 (09): : 1226 - 1226
[22] Quality of life assessment of relapsing-remitting multiple sclerosis patients on long-term treatment with Betaferon
Davidescu, I.
Damian, G.
EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 129 - 129
[23] Radiological Evidence for the Long-Term Effect of Fingolimod Treatment in Patients with Relapsing-Remitting Multiple Sclerosis
Cohen, Jeffrey
Tenenbaum, Nadia
Bhatt, Alit
Pimentel, Ron
Kappos, Ludwig
NEUROLOGY, 2017, 89 (08) : E103 - E103
[24] Serum neurofilament light chain predicts disease activity in relapsing remitting multiple sclerosis
Varhaug, K.
Barro, C.
Bjornevik, K.
Torkildsen, O.
Wergeland, S.
Bindoff, L. A.
Kuhle, J.
Vedeler, C. A.
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 589 - 590
[25] Alemtuzumab Reduces Serum Neurofilament Light Chain Levels in Relapsing-Remitting Multiple Sclerosis Patients with Highly Active Disease: CARE-MS I
Kuhle, Jens
Daizadeh, Nadia
Barro, Christian
Michalak, Zuzanna
Leppert, David
Godin, Jean
Shankara, Srinivas
Samad, Tarek
Jacobs, Alan
Chung, Luke
Roesch, Nora
Kaiser, Carina
Havari, Evis
Kappos, Ludwig
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 20 - 21
[26] Neurofilament light chain in human blood is a predictor of disease worsening in relapsing-remitting multiple sclerosis
Kuhle, J.
Kropshofer, H.
Haring, D. A.
Barro, C.
Kappos, L.
Leppert, D.
Tomic, D.
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 298 - 299
[27] Including Blood Neurofilament Light Chain in the NEDA Concept in Relapsing-Remitting Multiple Sclerosis Trials
Sormani, Maria Pia
Kappos, Ludwig
Haring, Dieter
Kropshofer, Harald
Barro, Christian
Leppert, David
Tomic, Davorka
Kuhle, Jens
NEUROLOGY, 2018, 90
[28] Increased Level of Caspase-1 in the Serum of Relapsing-remitting Multiple Sclerosis (RRMS) Patients
Beheshti, Masoumeh
Salehi, Zahra
Abolfazli, Roya
Shirzad, Hedayatolah
Izad, Maryam
IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2020, 19 (05) : 534 - 538
[29] REAL WORLD EVIDENCE (RWE) ON LONG-TERM PERSISTENCE OF FINGOLIMOD IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) IN AUSTRALIA
Walker, Robert
Schulz, Mark
Arora, Birendra
Chung, Eric
Juneja, Prabhjot
Verhaeghe, Stephane
Spelman, Tim
Broadley, Simon
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06): : E23 - E24
[30] REAL WORLD EVIDENCE (RWE) ON LONG-TERM PERSISTENCE OF FINGOLIMOD IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) IN AUSTRALIA
Schulz, M.
Arora, B.
Walker, R.
Verhaeghe, S.
Chung, E.
Juneja, P.
Spelman, T.
Butzkueven, H.
Broadley, S.
VALUE IN HEALTH, 2017, 20 (09) : A718 - A719

← 1 2 3 4 5 →